Risperidone ODT 3mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To take this medication correctly, follow your doctor's instructions and read all the information provided. You can take it with or without food. Continue taking the medication as directed by your doctor or healthcare provider, even if you're feeling well.
When taking the medication, make sure to:
Remove it from the blister pack only when you're ready to take it
Take it immediately after opening the blister pack
Do not store the removed medication for future use
Use dry hands to remove the tablet from the foil
Place the tablet on your tongue and let it dissolve; water is not needed
Do not swallow the tablet whole, chew, break, or crush it
Storing and Disposing of Your Medication
To store your medication properly:
Keep it at room temperature, protected from light
Store it in a dry place, away from the bathroom
Keep all medications in a safe place, out of the reach of children and pets
When disposing of your medication:
Throw away any unused or expired medication
Do not flush it down the toilet or pour it down the drain unless instructed to do so
Check with your pharmacist for guidance on the best way to dispose of medication; you may also have access to drug take-back programs in your area
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses.
Lifestyle & Tips
- Avoid alcohol and other CNS depressants, as they can increase drowsiness and dizziness.
- Be cautious when driving or operating machinery until you know how the medication affects you.
- Stay hydrated to help prevent orthostatic hypotension.
- Monitor your diet and engage in regular physical activity to help manage potential weight gain and metabolic changes.
- Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms or worsening of your condition.
- Inform your doctor about all other medications, supplements, and herbal products you are taking.
Available Forms & Alternatives
Available Strengths:
- Risperidone ODT 0.25mg Tablets
- Risperidone 1mg/ml Oral Soln 30ml
- Risperidone ODT 2mg Tablets
- Risperidone ODT 0.5mg Tablets
- Risperidone 0.5mg Tablets
- Risperidone 3mg Tablets
- Risperidone 4mg ODT Tablets
- Risperidone 1mg Tablets
- Risperidone 0.25mg Tablets
- Risperidone 2mg Tablets
- Risperidone 4mg Tablets
- Risperidone ODT 3mg Tablets
- Risperidone ODT 1mg Tablets
- Risperidone ER 25mg Inj Susp Kit
- Risperidone ER 50mg Inj Susp Kit
- Risperidone ER 37.5mg Inj Susp Kit
- Risperidone ER 12.5mg Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood sugar, including:
+ Confusion
+ Feeling sleepy
+ Unusual thirst or hunger
+ Passing urine more often
+ Flushing
+ Fast breathing
+ Breath that smells like fruit
Severe dizziness or passing out
Changes in behavior or mood
Shakiness, trouble moving around, or stiffness
Urination problems, such as inability to pass urine or changes in urine output
Trouble swallowing or speaking
Difficulty focusing
Seizures
Changes in eyesight
Shortness of breath
Drooling
Feeling extremely hot or cold
Hormonal changes, including:
+ Enlarged breasts
+ Nipple discharge
+ Erectile dysfunction or changes in menstrual cycle
Sexual problems, such as:
+ Decreased interest in sex
+ Ejaculation problems
Prolonged or painful erections (lasting more than 4 hours), which can lead to permanent sexual dysfunction if left untreated
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking or behavior
+ Fast or irregular heartbeat
+ Excessive sweating
Low white blood cell count, which can increase the risk of infection; if you have a history of low white blood cell count, inform your doctor and seek medical attention if you experience:
+ Fever
+ Chills
+ Sore throat
Tardive dyskinesia, a rare but potentially irreversible condition, characterized by:
+ Involuntary body movements
+ Problems with tongue, face, mouth, or jaw movements, such as tongue sticking out, puffing cheeks, mouth puckering, or chewing
Other Possible Side Effects
While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:
Weight gain
Restlessness
Dizziness, sleepiness, tiredness, or weakness
Anxiety
Gastrointestinal problems, such as:
+ Constipation
+ Diarrhea
+ Stomach pain
+ Upset stomach
+ Nausea or vomiting
Heartburn
Dry mouth
Changes in appetite
Common cold symptoms
Headache
Sleep disturbances
* Back, muscle, arm, or leg pain
If you experience any of these side effects or have concerns, contact your doctor or seek medical attention. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Fever, muscle stiffness, confusion, sweating, or fast/irregular heartbeat (signs of Neuroleptic Malignant Syndrome)
- Uncontrolled muscle movements, especially of the face, tongue, or limbs (signs of tardive dyskinesia)
- Dizziness or fainting, especially when standing up (orthostatic hypotension)
- Difficulty swallowing
- New or worsening high blood sugar symptoms (increased thirst, increased urination, increased hunger)
- Breast enlargement, milk production, or missed periods (hyperprolactinemia)
- Prolonged or painful erection (priapism)
- Signs of infection (fever, sore throat)
- Seizures
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial to avoid potential interactions between this medication and other substances.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is vital to verify that this medication is compatible with all your medications and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other activities that require you to be alert. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.
Potential Side Effects and Risks
It may take several weeks to experience the full effects of this medication. Be aware that high blood sugar, diabetes, high cholesterol, and weight gain have been associated with similar medications, which may increase the risk of heart and brain blood vessel disease.
Monitoring and Follow-up
Regularly check your blood sugar levels as instructed by your doctor. Additionally, have your blood work checked as directed by your doctor and discuss the results with them.
Interactions with Other Substances
Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis, or prescription/over-the-counter medications that may cause drowsiness, consult with your doctor.
Precautions in Hot Weather and Physical Activity
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent dehydration.
Dizziness and Fall Risk
This medication may cause dizziness, drowsiness, and impaired balance, which can increase the risk of falls, broken bones, and other health problems.
Special Considerations
If you have phenylketonuria (PKU), consult with your doctor, as some products contain phenylalanine.
Older adults with dementia who take medications like this one have a higher risk of stroke, which can be fatal. This medication is not approved for treating dementia-related mental health issues.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
This medication may affect fertility, but this effect is reversible when the medication is stopped. If you have concerns, discuss them with your doctor.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the benefits and risks to you and your baby.
Taking this medication during the third trimester of pregnancy may cause side effects or withdrawal symptoms in the newborn.
Overdose Information
Overdose Symptoms:
- Drowsiness
- Sedation
- Tachycardia (fast heart rate)
- Hypotension (low blood pressure)
- QT prolongation
- Extrapyramidal symptoms (e.g., muscle stiffness, tremors)
- Seizures
What to Do:
Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Management is supportive, including maintaining an open airway, ensuring adequate oxygenation and ventilation, and monitoring cardiac function (ECG) and vital signs. Activated charcoal may be considered if ingested recently.
Drug Interactions
Major Interactions
- CNS depressants (e.g., alcohol, opioids, benzodiazepines): Enhanced sedation and CNS depression.
- CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): Increase plasma concentrations of risperidone and decrease 9-hydroxyrisperidone, leading to increased overall active moiety.
- CYP3A4 inducers (e.g., carbamazepine, rifampin, phenytoin): Decrease plasma concentrations of risperidone and 9-hydroxyrisperidone, potentially reducing efficacy.
- Dopamine agonists (e.g., levodopa, bromocriptine): Risperidone may antagonize their effects.
- Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, moxifloxacin, thioridazine): Additive QT prolongation risk.
- Antihypertensives: Additive hypotensive effects.
Moderate Interactions
- Cimetidine, ranitidine: May increase risperidone levels (minor effect).
- Verapamil: May increase risperidone and 9-hydroxyrisperidone levels.
- Furosemide: Increased mortality in elderly dementia patients when co-administered with risperidone (observational study, mechanism unclear).
Monitoring
Baseline Monitoring
Rationale: Risk of weight gain, especially in children and adolescents.
Timing: Before initiation
Rationale: Risk of orthostatic hypotension and tachycardia.
Timing: Before initiation (supine and standing)
Rationale: Risk of hyperglycemia and diabetes.
Timing: Before initiation
Rationale: Risk of dyslipidemia.
Timing: Before initiation
Rationale: Rare risk of leukopenia/neutropenia/agranulocytosis.
Timing: Before initiation
Rationale: To assess baseline hepatic function.
Timing: Before initiation
Rationale: To assess baseline renal function, as dose adjustments are needed in impairment.
Timing: Before initiation
Rationale: To assess for baseline QT prolongation, especially in patients with cardiac risk factors.
Timing: Before initiation (if clinically indicated)
Rationale: Risk of hyperprolactinemia.
Timing: Before initiation (if clinically indicated or symptomatic)
Rationale: To establish baseline for tardive dyskinesia.
Timing: Before initiation
Routine Monitoring
Frequency: Monthly for first few months, then quarterly.
Target: Maintain healthy BMI.
Action Threshold: Significant weight gain (e.g., >5% of baseline) warrants intervention.
Frequency: Monthly for first few months, then quarterly.
Target: Within normal limits, no significant orthostatic changes.
Action Threshold: Persistent orthostatic hypotension or significant tachycardia.
Frequency: At 3 months, then annually.
Target: <100 mg/dL
Action Threshold: β₯100 mg/dL (prediabetes) or β₯126 mg/dL (diabetes).
Frequency: At 3 months, then annually.
Target: LDL <100 mg/dL, HDL >40 mg/dL, Triglycerides <150 mg/dL
Action Threshold: Significant dyslipidemia.
Frequency: Annually (more frequently if symptoms develop).
Target: No abnormal movements.
Action Threshold: Emergence or worsening of involuntary movements.
Frequency: As clinically indicated (e.g., if symptoms of hyperprolactinemia occur).
Target: Within normal limits.
Action Threshold: Elevated levels with associated symptoms (e.g., amenorrhea, galactorrhea, gynecomastia, sexual dysfunction).
Symptom Monitoring
- Extrapyramidal symptoms (EPS): Dystonia, akathisia, parkinsonism, tardive dyskinesia
- Orthostatic hypotension (dizziness, lightheadedness upon standing)
- Sedation/drowsiness
- Weight gain
- Hyperglycemia (increased thirst, urination, hunger)
- Dyslipidemia
- Hyperprolactinemia (galactorrhea, amenorrhea, gynecomastia, sexual dysfunction)
- Neuroleptic Malignant Syndrome (NMS): Fever, muscle rigidity, altered mental status, autonomic instability
- Seizures
- QT prolongation (palpitations, syncope)
- Dysphagia
- Priapism
- Body temperature dysregulation
Special Patient Groups
Pregnancy
Category C. Studies in animals have shown adverse effects on the fetus. There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Neonates exposed to antipsychotic drugs during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery.
Trimester-Specific Risks:
Lactation
Risperidone and its active metabolite are excreted in human breast milk. The decision to breastfeed should consider the developmental and health benefits of breastfeeding, the motherβs clinical need for risperidone, and any potential adverse effects on the breastfed infant from risperidone or from the underlying maternal condition. Monitor breastfed infants for sedation, poor feeding, and developmental milestones.
Pediatric Use
Approved for specific indications: schizophrenia (13-17 years), bipolar mania (10-17 years), and irritability associated with autistic disorder (5-16 years). Children and adolescents may be more susceptible to weight gain, metabolic changes, and hyperprolactinemia. Close monitoring of growth, weight, metabolic parameters, and prolactin levels is essential.
Geriatric Use
Elderly patients with dementia-related psychosis treated with risperidone are at an increased risk of death (Black Box Warning). Increased risk of cerebrovascular adverse events (e.g., stroke, transient ischemic attack) in elderly patients with dementia. Start with lower doses and titrate slowly due to potential for increased sensitivity to adverse effects (e.g., orthostatic hypotension, sedation, EPS).
Clinical Information
Clinical Pearls
- Risperidone ODT (Orally Disintegrating Tablet) is useful for patients who have difficulty swallowing pills or who may try to 'cheek' or hide their medication.
- The ODT formulation should be placed on the tongue and allowed to dissolve, then swallowed with or without water. Do not chew or crush.
- Monitor patients closely for metabolic side effects (weight gain, hyperglycemia, dyslipidemia), especially in children and adolescents.
- Hyperprolactinemia is a common side effect; monitor for symptoms like galactorrhea, amenorrhea, gynecomastia, and sexual dysfunction.
- Titrate dose slowly to minimize orthostatic hypotension and other dose-related side effects.
- Educate patients and caregivers about the Black Box Warning regarding increased mortality in elderly patients with dementia-related psychosis.
- Consider the long half-life of the active metabolite (9-hydroxyrisperidone) when adjusting doses or assessing steady-state effects.
Alternative Therapies
- Other atypical antipsychotics (e.g., Olanzapine, Quetiapine, Aripiprazole, Ziprasidone, Lurasidone, Cariprazine, Brexpiprazole)
- Typical antipsychotics (e.g., Haloperidol, Chlorpromazine) - generally less preferred due to higher EPS risk
- Mood stabilizers (e.g., Lithium, Valproate, Carbamazepine) for bipolar disorder
- SSRIs/SNRIs for mood/anxiety symptoms (if comorbid)
- Behavioral therapies and psychosocial interventions